Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Case Reports

Timing of resumption of immune checkpoint inhibitor therapy after successful control of immune-related adverse events in seven advanced non-small cell lung cancer patients

Kashiwabara, Kosuke; Fujii, Shinji; Tsumura, Shinsuke; Sakamoto, Kazuhiko

Author Information
doi: 10.1097/CAD.0000000000000957
  • Buy

Abstract

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.